The effect of preservative-free HP-Guar on dry eye after phacoemulsification: a flow cytometric study

Eye (Lond). 2010 Aug;24(8):1331-7. doi: 10.1038/eye.2010.24. Epub 2010 Mar 19.

Abstract

Purpose: To assess the effect of hydroxypropyl (HP)-Guar added to regular post-phacoemulsification treatment in dry eye signs and symptoms, and its influence on the expression of various inflammatory markers by flow cytometry (FCM) in impression cytology specimens.

Methods: This prospective, interventional, single-centre study included 48 eyes of 48 patients with age-related cataract. After phacoemulsification, patients were randomised to the usual treatment group (UT), with 21 patients who received tobramycin and dexamethasone eye drops (Tobradex, Alcon Cusí, Spain), and the HP-Guar group, with 27 patients who received the UT plus preservative-free artificial tears (Systane UD, Alcon Cusí, Spain). Corneal and conjunctival staining with fluorescein and lissamine green, tear film break-up time (TBUT), Schirmer's I test with anaesthesia (Jones test), tear clearance, and ocular surface disease index (OSDI) were assessed preoperatively and 1 month after surgery. Besides, conjunctival impression cytology was performed in order to investigate inflammatory markers (CD3, CD11b, and HLA-DR) using FCM.

Results: HP-Guar group shows statistical better results compared with the UT group in TBUT (6.4+/-0.7 vs 9+/-2.5, P=0.0004), OSDI (11.5+/-8.2 vs 3.3+/-2.5, P=0.0002), ocular symptoms subscale (7.3+/-6.1 vs 1.7+/-1.8, P=0.0004), vision-related function subscale (2.2+/-1.8 vs 0.4+/-0.6, P=0.0002), CD3 (2.5+/-1.4 vs 1.1+/-1.1, P=0.011), and HLA-DR (6.8+/-4.5 vs 1.8+/-1.7, P=0.0002).

Conclusion: The addition of HP-Guar to regular treatment after cataract surgery reduces ocular surface inflammation and dry eye signs and symptoms.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / therapeutic use
  • Antigens, CD / metabolism
  • Biomarkers / metabolism
  • Conjunctiva / drug effects
  • Conjunctiva / metabolism
  • Cornea / drug effects
  • Dexamethasone / therapeutic use
  • Dry Eye Syndromes / etiology
  • Dry Eye Syndromes / physiopathology
  • Dry Eye Syndromes / prevention & control*
  • Female
  • Flow Cytometry
  • HLA-DR Antigens / metabolism
  • Humans
  • Male
  • Ophthalmic Solutions / pharmacology*
  • Phacoemulsification / adverse effects*
  • Polysaccharides / pharmacology*
  • Prospective Studies
  • Tears / physiology
  • Tobramycin / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Antigens, CD
  • Biomarkers
  • HLA-DR Antigens
  • Ophthalmic Solutions
  • Polysaccharides
  • hydroxypropyl guar
  • Dexamethasone
  • Tobramycin